This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Novo Nordisk A/s, Other. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2000-2002
Title: Tina Moller Tagmose: Innovator in Pharmaceutical Chemistry
Introduction
Tina Moller Tagmose is a prominent inventor based in Ballerup, Denmark. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications. With a total of 4 patents to her name, her work is recognized for its innovative approach to treating various medical conditions.
Latest Patents
Among her latest patents are "Tetrahydronaphtalene derivatives and their use" and "Substituted 3,3-diamino-2-propenenitriles, their preparation and use." The tetrahydronaphthalene derivatives are particularly noteworthy as they are useful in inhibiting a rise in intracellular calcium mediated by an influx through T-type calcium channels. This makes them valuable for the treatment of type 1 and type 2 diabetes, as well as cardiovascular diseases associated with diabetes.
Career Highlights
Tina has worked with notable companies, including Novo Nordisk A/S, where she has contributed to various research initiatives. Her expertise in pharmaceutical chemistry has positioned her as a key player in the development of innovative treatments.
Collaborations
Throughout her career, Tina has collaborated with esteemed colleagues such as John Bondo Hansen and John Patrick Mogensen. These partnerships have further enhanced her research and development efforts.
Conclusion
Tina Moller Tagmose is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the medical field. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile